Price, D. B.Cotton, S.Fielding, S.McMeekin, N.Barnes, P.Briggs, A.Burns, G.Chaudhuri, R.Chrystyn, H.Davies, L.De Soyza, A.Gompertz, S.Haughney, J.Lee, A.Morice, A.Norrie, J.Sullivan, A.Wilson, A.Devereux, G.2018-06-112018-06-112018-05Price, D B, Cotton, S, Fielding, S, McMeekin, N, Barnes, P, Briggs, A, Burns, G, Chaudhuri, R, Chrystyn, H, Davies, L, De Soyza, A, Gompertz, S, Haughney, J, Lee, A, Morice, A, Norrie, J, Sullivan, A, Wilson, A & Devereux, G 2018, 'Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled Trial', American Journal of Respiratory and Critical Care Medicine, vol. 197, A7709. < https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709 >1073-449XRIS: urn:9EE66195E7735A26C9A3E6411F040C3Chttp://hdl.handle.net/2164/10580This abstract is funded by: National Institute for Health Research Health Technology Assessment Presented at mini symposium: B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD Monday 21st May 20182208518engR Medicine (General)National Institute for Health Research (NIHR)R1Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled TrialJournal itemhttps://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709197